Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Suramin inhibits liver cell apoptosis in vitro and in vivo

July 9, 2003

Antiviral efficacy of NM-283 shown in HCV-infected chimpanzees

July 8, 2003

Positive Japanese phase III data for Zadaxin in hepatitis B

July 2, 2003

Cypress Bioscience prepares for milnacipran trial in IBS

July 2, 2003

Serostim not recommended for short bowel syndrome

July 1, 2003

FDA clears IND for dextofisopam for IBS

June 30, 2003

Gilead and Bukwang clevudine licensing agreement terminated

June 30, 2003

DOR BioPharma pursues second indication for orBec

June 25, 2003

Enzo Biochem's new Crohn's disease therapy enters phase II

June 20, 2003

Nippon Shinyaku patent covers new TGF-beta antagonists

June 16, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...